Managing Partner
CurrentHealthcare Private EquityHealthcare Venture CapitalSpecialty Pharmaceuticals, MedTech and IT Enabled ServicesMr. Jahns is a Managing Director of Galen Partners, a leading healthcare growth equity investment firm founded in 1990. With experience in over 70 growth equity investments, Mr. Jahns has developed substantial expertise and leadership in working with entrepreneurs to build market-leading healthcare companies in the areas of medical devices and technology-enabled services. As an investment banker and venture capitalist, Mr. Jahns has worked on more than 20 initial public offerings, including 11 Galen portfolio companies’ IPOs. Additionally, he has extensive M&A experience including 19 portfolio companies’ sales to financial and strategic buyers.Mr. Jahns has served on numerous public company Boards of Directors and currently serves several Galen portfolio companies including: CBL Pathology, Dakim Brain Fitness, Unisyn Medical Technologies, PeriGen, InTouch Health, and USHIFU.Galen has enjoyed a long and successful track record of partnering with experienced and driven management teams to build large, sustainable businesses. Galen achieves this by leveraging healthcare experience and a network of industry relationships to help provide management partners with the necessary resources and support to create and implement impressive growth plans. Since 1990, Galen has built an investment portfolio with an aggregate market value of over $10 billion–and helped 70 of our portfolio companies navigate through the complicated paths of public offerings, debt financings, and mergers and acquisitions. As such, over the past decade we have gained recognition as one of the largest and most influential names in healthcare private equity investing.
